Similar articles for PMID: 30843305

Year	Number of Results
1893	1
1897	1
1949	1
1987	1
2011	4
2012	7
2013	10
2014	21
2015	22
2016	14
2017	7
2018	8
2019	11
2020	5
2021	2
2022	3
2023	2
2024	0

1

Decalcification can cause the failure of BRAF molecular analyses and anti-BRAFV600E VE1 immunohistochemistry.

Bourhis A, Le Flahec G, Uguen A. Bourhis A, et al. Pathol Int. 2019 Apr;69(4):219-223. doi: 10.1111/pin.12784. Epub 2019 Mar 7. Pathol Int. 2019. PMID: 30843305

2

Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice.

Uguen A, Guéguen P, Legoupil D, Bouvier S, Costa S, Duigou S, Lemasson G, Ledé F, Sassolas B, Talagas M, Férec C, Le Maréchal C, De Braekeleer M, Marcorelles P. Uguen A, et al. Hum Pathol. 2015 Nov;46(11):1582-91. doi: 10.1016/j.humpath.2015.06.023. Epub 2015 Jul 15. Hum Pathol. 2015. PMID: 26297254

3

Validation of a Manual Protocol for BRAF V600E Mutation-specific Immunohistochemistry.

Dinges HC, Capper D, Ritz O, Brüderlein S, Marienfeld R, von Deimling A, Möller P, Lennerz JK. Dinges HC, et al. Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):382-8. doi: 10.1097/PAI.0000000000000092. Appl Immunohistochem Mol Morphol. 2015. PMID: 25611237

4

Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.

Brown NA, Betz BL, Weigelin HC, Elenitoba-Johnson KS, Lim MS, Bailey NG. Brown NA, et al. Am J Clin Pathol. 2015 Jan;143(1):89-99. doi: 10.1309/AJCPDN4Q1JTFGCFC. Am J Clin Pathol. 2015. PMID: 25511147

5

The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.

Uppal G, Ly V, Wang ZX, Bajaj R, Solomides CC, Banks PM, Medeiros LJ, Peiper SC, Gong JZ. Uppal G, et al. Am J Clin Pathol. 2015 Jan;143(1):120-5. doi: 10.1309/AJCPQLQ89VXTVWKN. Am J Clin Pathol. 2015. PMID: 25511150

6

[Immunohistochemistry using clone VE1 is an economic, specific and sensitive method for detecting the presence of BRAFV600E mutations in melanoma].

Etienne M, Oca F, Prunier-Mirebeau D, Croué A, Martin L. Etienne M, et al. Ann Dermatol Venereol. 2018 Mar;145(3):159-165. doi: 10.1016/j.annder.2017.10.011. Epub 2017 Dec 6. Ann Dermatol Venereol. 2018. PMID: 29221650 French.

7

BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases.

Eriksson H, Zebary A, Vassilaki I, Omholt K, Ghaderi M, Hansson J. Eriksson H, et al. JAMA Dermatol. 2015 Apr;151(4):410-6. doi: 10.1001/jamadermatol.2014.3689. JAMA Dermatol. 2015. PMID: 25588152

8

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France).

Long E, Ilie M, Lassalle S, Butori C, Poissonnet G, Washetine K, Mouroux J, Lespinet V, Lacour JP, Taly V, Laurent-Puig P, Bahadoran P, Hofman V, Hofman P. Long E, et al. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2436-43. doi: 10.1111/jdv.13332. Epub 2015 Sep 16. J Eur Acad Dermatol Venereol. 2015. PMID: 26377147

9

A comparison of high resolution melting, allele-specific priming and Sanger sequencing for the detection of BRAFV600E mutation in hairy cell leukaemia from different haematological specimens.

So CC, Chan A, Chung LP, Siu L, Wong WS, Wong KF. So CC, et al. Pathology. 2014 Oct;46(6):533-7. doi: 10.1097/PAT.0000000000000151. Pathology. 2014. PMID: 25158814

10

VE1 Immunohistochemistry Fails to Detect Most of the Non-BRAFV600E Mutations in Melanoma.

Uguen A, Uguen M. Uguen A, et al. Appl Immunohistochem Mol Morphol. 2016 Nov/Dec;24(10):e98-e99. doi: 10.1097/PAI.0000000000000341. Appl Immunohistochem Mol Morphol. 2016. PMID: 26894646 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year